Watchlist Price Alert

Lyell Immunopharma Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

10.07

0.33 (3.39%)

At close: Jun 16, 2025, 3:59 PM

Lyell Immunopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	105.6M	145.65M	123.55M	293.83M	140.41M	96.67M
Short-Term Investments	264.93M	400.58M	516.6M	320.97M	472.21M	339.38M
Long-Term Investments	32.01M	48.51M	115.04M	330.53M	163.44M	68.98M
Other Long-Term Assets	6.31M	4.52M	4.96M	3.95M	3.23M	2.68M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	9.07M	8.46M	11.14M	11.49M	n/a	4.21M
Total Current Assets	379.59M	554.69M	651.29M	626.29M	617.55M	440.26M
Property-Plant & Equipment	72.94M	142.32M	166.26M	166.64M	124.06M	43.7M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	111.27M	195.34M	286.27M	501.12M	290.73M	115.37M
Total Assets	490.86M	750.03M	937.56M	1.13B	908.28M	555.63M
Account Payables	5.37M	4.82M	3.92M	3.21M	9.4M	2.84M
Deferred Revenue	n/a	n/a	21.87M	4.99M	6.09M	4.51M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	22.72M	8.79M	13.13M	20.08M	15.33M	5.43M
Total Current Liabilities	53.79M	34.52M	37.03M	46.74M	49.28M	22.05M
Long-Term Debt	n/a	n/a	63.17M	66.65M	n/a	n/a
Other Long-Term Liabilities	3.25M	3.66M	-59.05M	-62.08M	532K	n/a
Total Long-Term Liabilities	54.25M	60.56M	67.28M	150.88M	140.56M	125.53M
Total Liabilities	108.03M	95.08M	104.31M	197.62M	189.84M	147.58M
Total Debt	58.97M	63.17M	67.7M	67.82M	54.57M	27.47M
Common Stock	29K	25K	25K	24K	2K	1K
Retained Earnings	-1.35B	-1B	-767.48M	-584.36M	-334.14M	-129.67M
Comprehensive Income	291K	-94K	-7.6M	-1.62M	256K	454K
Shareholders Equity	382.82M	654.95M	833.25M	929.79M	718.44M	408.06M
Total Investments	283.93M	449.08M	631.64M	651.5M	635.66M	408.36M